Ticker LaunchUplisting · MEDS
Scienture Holdings, Inc.
Formerly TRxADE HEALTH, INC; TRXADE GROUP, INC.; XCELLINK INTERNATIONAL INC.
Scienture Holdings, Inc. (MEDS), already reporting to the SEC, moved up to a national exchange on Feb 14, 2020 with an offering at $6.50 per share raising $5.2M. Dawson James was lead-left underwriter, joined by Dougherty & Company and ViewTrade. Schiff Hardin advised the company.
At its 2020 uplisting, Trxade Group (now Scienture Holdings) ran Trxade.com, a web-based pharmaceutical marketplace linking independent pharmacies with pharmaceutical suppliers in the United States. It also operated InventoryRx, an exchange for wholesalers, and Integra Pharma Solutions, a licensed wholesaler.
- Status
- Uplisting
- Ticker
- MEDS
- Listed
- Feb 14, 2020
- Price
- $6.50
- Raised
- $5.2M
- Market cap at IPO price
- $47.7M
- First filed
- May 6, 2019
- Underwriters
- Dawson James, Dougherty & Company and ViewTrade
- Company counsel
- Schiff Hardin
- Sector
- Biotech & pharma
- Country / state
- NY
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed May 6, 2019
- Latest amendment Feb 12, 2020
- Final prospectus (424B4) Feb 14, 2020
- All filings on EDGAR CIK 1382574
Other Biotech & pharma uplistings in 2020
- Nomad Power Solutions, Inc.LIXT · Nov 27, 2020
- Processa Pharmaceuticals, Inc.PCSA · Oct 5, 2020 · $19.2M
- GeoVax Labs, Inc.GOVX · Sep 28, 2020 · $12.8M
- Biovie Inc.BIVI · Sep 18, 2020 · $15.7M
- Panbela Therapeutics, Inc.SNBP · Aug 31, 2020
- Windtree Therapeutics Inc /de/WINTD · May 21, 2020 · $20M